The biological indicator vial market was valued at USD 170.8 million in 2025, is projected to reach USD 280.1 million by 2036 and is forecast to register a 4.6% CAGR between 2026 and 2036, creating an incremental opportunity of USD 101.4 million. In 2026, direct sales hold 65% within the distribution segment.